These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23828566)
1. The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicity. Kook SH; Cho JS; Morrison A; Wiener E; Lee SB; Scadden D; Lee BC Cell Death Dis; 2013 Jul; 4(7):e703. PubMed ID: 23828566 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression. Scrivens M; Dickenson JM Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433 [TBL] [Abstract][Full Text] [Related]
3. Role of UDP-Sugar Receptor P2Y Mikolajewicz N; Komarova SV Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326617 [TBL] [Abstract][Full Text] [Related]
5. Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation. Lee SA; Park JH; Lee SY Mol Cells; 2013 Sep; 36(3):273-7. PubMed ID: 24048691 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763 [TBL] [Abstract][Full Text] [Related]
7. UDP-sugars activate P2Y Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618 [TBL] [Abstract][Full Text] [Related]
8. UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells. Katakura S; Takao T; Arase T; Yoshimasa Y; Tomisato S; Uchida S; Masuda H; Uchida H; Tanaka M; Maruyama T Placenta; 2020 Nov; 101():194-203. PubMed ID: 33011563 [TBL] [Abstract][Full Text] [Related]
9. UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation. Gao ZG; Ding Y; Jacobson KA Biochem Pharmacol; 2010 Mar; 79(6):873-9. PubMed ID: 19896471 [TBL] [Abstract][Full Text] [Related]
10. Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Carter RL; Fricks IP; Barrett MO; Burianek LE; Zhou Y; Ko H; Das A; Jacobson KA; Lazarowski ER; Harden TK Mol Pharmacol; 2009 Dec; 76(6):1341-8. PubMed ID: 19759354 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries. Haanes KA; Edvinsson L FEBS Lett; 2014 Aug; 588(17):2936-43. PubMed ID: 24911208 [TBL] [Abstract][Full Text] [Related]
12. Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. Skelton L; Cooper M; Murphy M; Platt A J Immunol; 2003 Aug; 171(4):1941-9. PubMed ID: 12902497 [TBL] [Abstract][Full Text] [Related]
13. Purinergic P2Y₁₄ receptor modulates stress-induced hematopoietic stem/progenitor cell senescence. Cho J; Yusuf R; Kook S; Attar E; Lee D; Park B; Cheng T; Scadden DT; Lee BC J Clin Invest; 2014 Jul; 124(7):3159-71. PubMed ID: 24937426 [TBL] [Abstract][Full Text] [Related]
14. Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor. Azroyan A; Cortez-Retamozo V; Bouley R; Liberman R; Ruan YC; Kiselev E; Jacobson KA; Pittet MJ; Brown D; Breton S PLoS One; 2015; 10(3):e0121419. PubMed ID: 25799465 [TBL] [Abstract][Full Text] [Related]
15. Functional expression of the P2Y14 receptor in human neutrophils. Scrivens M; Dickenson JM Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor. Ko H; Fricks I; Ivanov AA; Harden TK; Jacobson KA J Med Chem; 2007 May; 50(9):2030-9. PubMed ID: 17407275 [TBL] [Abstract][Full Text] [Related]
17. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils. Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514 [TBL] [Abstract][Full Text] [Related]
18. UDP is a competitive antagonist at the human P2Y14 receptor. Fricks IP; Maddileti S; Carter RL; Lazarowski ER; Nicholas RA; Jacobson KA; Harden TK J Pharmacol Exp Ther; 2008 May; 325(2):588-94. PubMed ID: 18252808 [TBL] [Abstract][Full Text] [Related]
19. Functional expression of the P2Y14 receptor in murine T-lymphocytes. Scrivens M; Dickenson JM Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228 [TBL] [Abstract][Full Text] [Related]
20. Empowering human cardiac progenitor cells by P2Y Khalafalla FG; Kayani W; Kassab A; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Norman B; Dembitsky WP; Sussman MA J Physiol; 2017 Dec; 595(23):7135-7148. PubMed ID: 28980705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]